batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Enhertu goes even lower 28 January 2025 Roche claims an Itovebi breast cancer survival benefit 28 January 2025 Novartis casts a broader Netter for Lutathera 28 January 2025 ASCO-GI – Braftovi shoots for a survival benefit 27 January 2025 ASCO-GI – Exelixis opens up its Cabinet again 27 January 2025 A curate's egg for Merck/Eisai's Leap 24 January 2025 ASCO-GI – Inhibrx presses ahead with DR5 23 January 2025 ArriVent ups its ADC bet 22 January 2025 Load More